We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+11.42%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.25B
AUM Growth
+$71.7M
Cap. Flow
+$66.5K
Cap. Flow %
0.01%
Top 10 Hldgs %
19.89%
Holding
377
New
103
Increased
164
Reduced
64
Closed
19

Top Buys

Rank Stock Value
1
INMD icon
InMode
INMD
+$18M
2
MRK icon
Merck
MRK
+$16.6M
3
BEKE icon
KE Holdings
BEKE
+$13.8M
4
PODD icon
Insulet
PODD
+$10.5M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$9.67M

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$38.1M
2
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$33.7M
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$32M
4
ABBV icon
AbbVie
ABBV
+$17.7M
5
LHCG
LHC Group LLC
LHCG
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 45.52%
2 Financials 14.68%
3 Consumer Discretionary 13.33%
4 Technology 10.6%
5 Industrials 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MFC icon
1
Manulife Financial
MFC
$73.2B
$29.1M 2.33%
1,204,270
+4,270
+0.4% +$72.8K
SCI icon
2
Service Corp International
SCI
$11.4B
$27.3M 2.18%
395,000
-5,000
-1% -$333K
CIXX
3
DELISTED
CI Financial Corp.
CIXX
$27M 2.16%
2,000,000
– –
TMO icon
4
Thermo Fisher Scientific
TMO
$222B
$26.2M 2.1%
47,639
+548
+1% +$290K
IQV icon
5
IQVIA
IQV
$40.2B
$25.2M 2.02%
123,018
+8,018
+7% +$1.63M
AMP icon
6
Ameriprise Financial
AMP
$49.9B
$25.1M 2.01%
80,702
-4,298
-5% -$1.31M
DXCM icon
7
DexCom
DXCM
$33.4B
$24.3M 1.94%
214,791
-35,057
-14% -$3.85M
BC icon
8
Brunswick
BC
$5.27B
$21.6M 1.73%
300,000
– –
SCHW
9
Charles Schwab
SCHW
$187B
$21.5M 1.72%
258,765
+4,744
+2% +$368K
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$13.4B
$21.3M 1.71%
206,213
-16,725
-8% -$1.57M
MRK icon
11
Merck
MRK
$321B
$20.2M 1.61%
181,952
+162,607
+841% +$16.6M
INCY icon
12
Incyte
INCY
$24.6B
$19.9M 1.59%
247,184
-18,889
-7% -$1.45M
PFE icon
13
Pfizer
PFE
$151B
$19.8M 1.58%
385,863
-45,035
-10% -$2.16M
CVS icon
14
CVS Health
CVS
$119B
$19.6M 1.57%
210,488
-32,800
-13% -$3.16M
UNH icon
15
UnitedHealth
UNH
$367B
$19M 1.52%
35,919
+236
+0.7% +$125K
LOW icon
16
Lowe's Companies
LOW
$125B
$18.8M 1.5%
94,325
+2,071
+2% +$414K
INMD icon
17
InMode
INMD
$871M
$18.4M 1.47%
+516,557
New +$18M
HALO icon
18
Halozyme
HALO
$11.7B
$17.9M 1.43%
314,048
-82,569
-21% -$4.23M
LH icon
19
Labcorp
LH
$26.2B
$17.8M 1.43%
88,133
+833
+1% +$163K
AXP icon
20
American Express
AXP
$231B
$17.7M 1.41%
119,726
-2,449
-2% -$363K
BMY icon
21
Bristol-Myers Squibb
BMY
$130B
$17.5M 1.4%
243,233
-45,161
-16% -$3.41M
ABT icon
22
Abbott
ABT
$189B
$17.5M 1.4%
159,163
+1,278
+0.8% +$132K
MED icon
23
Medifast
MED
$132M
$17.3M 1.39%
150,400
+400
+0.3% +$46.6K
KEYS icon
24
Keysight
KEYS
$58.4B
$17M 1.36%
99,232
-2,941
-3% -$501K
HOLX
25
DELISTED
Hologic
HOLX
$16.5M 1.32%
220,714
-54,286
-20% -$3.87M
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q4 2022 Portfolio in Review

As of Q4 2022, Lombard Odier Asset Management (Switzerland) held 377 positions worth $1.25B, up 6.1% from $1.18B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lombard Odier Asset Management (Switzerland)'s Q4 2022 filing shows 103 new, 164 increased, 64 reduced and 19 closed positions. Its largest new stake was InMode: 516,557 shares worth $18.4M. The largest sale was iShares Russell 1000 Value ETF, an estimated $38.1M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Lombard Odier Asset Management (Switzerland)'s largest Q4 2022 buy was InMode: 516,557 shares worth $18.4M.
  • Lombard Odier Asset Management (Switzerland) added most to Merck in Q4 2022, an estimated $16.6M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q4 2022 reduction was iShares Russell 1000 Value ETF, cutting an estimated $38.1M.
  • Lombard Odier Asset Management (Switzerland) fully exited iShares Russell 2000 Growth ETF in Q4 2022, selling an estimated $33.7M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 20% of its $1.25B portfolio in Q4 2022.
  • Lombard Odier Asset Management (Switzerland) opened 103 new positions and closed 19 in Q4 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value rose 6.1% quarter-over-quarter to $1.25B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 14 Feb 2023.